JAMP PENTOXIFYLLINE SR 400 MG
PENTOXIFYLLINE : 400 MG · DIN 02543087 · JAMP PHARMA CORPORATION
Health Canada status: MARKETED
What is JAMP PENTOXIFYLLINE SR?
JAMP PENTOXIFYLLINE SR 400 MG contains PENTOXIFYLLINE : 400 MG. It is listed in the Health Canada Drug Product Database under DIN 02543087, held by JAMP PHARMA CORPORATION, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 20-Sep-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is JAMP PENTOXIFYLLINE SR used for?
JAMP Pentoxifylline SR (pentoxifylline) is indicated for: symptomatic treatment of patients with chronic occlusive peripheral vascular disorders of the extremities. In such patients pentoxifylline may give relief of signs and symptoms of impaired blood flow, such as intermittent claudication or trophic ulcers.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02543087 |
|---|---|
| Brand name | JAMP PENTOXIFYLLINE SR |
| Generic / active ingredient | PENTOXIFYLLINE : 400 MG |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 400 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C04AD03 PENTOXIFYLLINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Sep-2024 |
How is it stored and handled?
Store at room temperature (15 - 30°C).
How is it supplied?
bottles of 100 and 500 tablets
Is PENTOXIFYLLINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by APOTEX INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C04AD03 PENTOXIFYLLINE. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-PENTOXIFYLLINE SR | 400 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02230090 |
| NU-PENTOXIFYLLINE-SR 400 MG | 400 MG | TABLET (EXTENDED-RELEASE) | NU-PHARM INC | CANCELLED POST MARKET | DIN 02230401 |
| RATIO-PENTOXIFYLLINE | 400 MG | TABLET (EXTENDED-RELEASE) | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 01968432 |
| TRENTAL | 400 MG | TABLET (EXTENDED-RELEASE) | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | DIN 02221977 |
| TRENTAL SRT 400MG | 400 MG | TABLET (EXTENDED-RELEASE) | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | DIN 01989685 |
| TRENTAL TAB 400MG | 400 MG | TABLET (EXTENDED-RELEASE) | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00586625 |
Who else supplies PENTOXIFYLLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PENTOXIFYLLINE appears in 24 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.